Ginkgo Bioworks Holdings, Inc.
DNA
$8.81
$0.2552.98%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -472.08M | -547.03M | -651.19M | -897.68M | -853.81M |
| Total Depreciation and Amortization | 65.52M | 63.02M | 60.21M | 64.10M | 64.42M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 226.26M | 254.09M | 305.80M | 482.13M | 466.56M |
| Change in Net Operating Assets | -101.55M | -89.67M | -49.79M | 46.42M | 28.66M |
| Cash from Operations | -281.85M | -319.59M | -334.98M | -305.03M | -294.17M |
| Capital Expenditure | -63.45M | -62.54M | -52.28M | -41.57M | -28.07M |
| Sale of Property, Plant, and Equipment | 648.00K | 648.00K | 2.02M | 1.69M | 4.43M |
| Cash Acquisitions | 0.00 | -5.40M | -5.40M | -5.40M | -5.40M |
| Divestitures | -- | -- | -42.98M | -42.98M | -42.98M |
| Other Investing Activities | -186.01M | 5.06M | 2.81M | -750.00K | -1.37M |
| Cash from Investing | -248.81M | -62.24M | -95.83M | -89.01M | -73.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -810.00K | -897.00K | -1.01M | -1.14M | -1.27M |
| Issuance of Common Stock | 14.00K | 84.00K | 98.00K | 153.00K | 151.00K |
| Repurchase of Common Stock | -- | -- | -23.00K | -23.00K | -23.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -305.00K | -926.00K | -1.23M | -1.01M | -2.03M |
| Cash from Financing | -1.10M | -1.74M | -2.17M | -2.02M | -3.17M |
| Foreign Exchange rate Adjustments | -50.00K | -281.00K | -106.00K | -266.00K | -719.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -531.81M | -383.84M | -433.08M | -396.32M | -371.46M |